To confirm the contribution of M2 macrophage-derived TGF-β signaling on hepatoma cell growth, we performed TGF-β receptor blocking experiments using the specific phosphorylation inhibitor LY2157299. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.